from the Gladstone Institute and University of California Berkeley
CRISPR based diagnostics are new technologies to diagnose human disease. DirectBio’s innovation is an amplification free CRISPR diagnostics. Amplification free means that errors leading to false diagnostic results are minimized and the diagnostic is thus more precisely, faster, and cheaper. DirectBio Inc. was founded to productize and commercialize this new class of diagnostic technologies.